MedTrace Logo

Effects of Drugs on Responses to Brain and Emotional Processes

NCT04053036 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2024-11-25

Study results available
· View outcomes & findings →

Summary

To study the effects of a psychostimulant on responses to affective touch in individuals with a range of autistic traits

Conditions

Interventions

DRUG

MDMA

Participants will be given 1.5mg/kg of MDMA

DRUG

Placebo oral tablet

Participants will be given a placebo capsule that will only contain lactose.

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Harriet de Wit · Principal Investigator

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-08
Primary Completion
2021-04-12
Completion
2021-04-12
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04053036 on ClinicalTrials.gov